Vaccine update: issue 315, December 2020, COVID-19 special edition

Vaccine update: issue 315, December 2020, COVID-19 special edition (print version) Ref: PHE gateway number 2020372 PDF, 2.78MB, 21 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more …
Continue reading Vaccine update: issue 315, December 2020, COVID-19 special edition

COVID-19 (SARS-CoV-2): E53 sequencing request form

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use. Source link

Confirmed cases of COVID-19 variant from South Africa identified in UK

The 2 cases were identified in the UK on 22 December 2020 and both have been in contact with someone who has travelled from South Africa. Public Health England’s Health Protection Teams have followed up with both cases and contact tracing is underway. The new variant named B1.351 (also referred to as 501Y.V2) was first …
Continue reading Confirmed cases of COVID-19 variant from South Africa identified in UK

Rapid evaluation confirms lateral flow devices effective in detecting new COVID-19 variant

Scientists at PHE’s Porton Down laboratory have carried out a rapid evaluation using clinical and laboratory grown samples containing the VUI 202012/01 variant to test whether it can be detected by lateral flow devices (LFDs) currently in use across the country. Five LFDs were tested. Each device is either in use as part of mass …
Continue reading Rapid evaluation confirms lateral flow devices effective in detecting new COVID-19 variant

SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01

Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 60 have been considered to date, approximately 30% of which have progressed to extended evaluation on clinical samples at Phase 3. Source link

Multiphase optimization strategy (MOST) – GOV.UK

This guidance is part of a guide to evaluating digital health products. Digital health products and services are usually made up of various features (multicomponent interventions). However, they are often assessed as a package and we are unable to tell which components of the interventions are effective and which are non-essential. Multiphase optimization strategy (MOST) …
Continue reading Multiphase optimization strategy (MOST) – GOV.UK

Interrupted time series study – GOV.UK

An interrupted time series (ITS) design involves collecting data consistently before and after an interruption. This means introducing and withdrawing your digital product or service, or some part of it. It is a useful design to demonstrate cause and effect of your digital product without randomising to different conditions – for example, as you would …
Continue reading Interrupted time series study – GOV.UK